Using deep learning to predict anti-PD-1 response in melanoma and lung cancer patients from histopathology images
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Using deep learning to predict anti-PD-1 response in melanoma and lung cancer patients from histopathology images
Authors
Keywords
Deep learning, Immunotherapy, H&E slides
Journal
Translational Oncology
Volume 14, Issue 1, Pages 100921
Publisher
Elsevier BV
Online
2020-10-28
DOI
10.1016/j.tranon.2020.100921
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence and mutational determinants of high tumor mutation burden in breast cancer
- (2020) R. Barroso-Sousa et al. ANNALS OF ONCOLOGY
- Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%
- (2020) J.F. Gainor et al. ANNALS OF ONCOLOGY
- Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer
- (2020) Sohyun Hwang et al. Scientific Reports
- Neoantigen-directed immune escape in lung cancer evolution
- (2019) Rachel Rosenthal et al. NATURE
- Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
- (2019) Jakob Nikolas Kather et al. NATURE MEDICINE
- Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
- (2019) Gabriele Campanella et al. NATURE MEDICINE
- A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)
- (2019) Lu Si et al. Translational Oncology
- Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non–Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab
- (2018) Brandon W. Higgs et al. CLINICAL CANCER RESEARCH
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images
- (2018) Joel Saltz et al. Cell Reports
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
- (2018) Noam Auslander et al. NATURE MEDICINE
- Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
- (2018) Nicolas Coudray et al. NATURE MEDICINE
- Interferon gamma in cancer immunotherapy
- (2018) Ling Ni et al. Cancer Medicine
- Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
- (2018) Razvan Cristescu et al. SCIENCE
- Advances in Immunotherapy for Melanoma: A Comprehensive Review
- (2017) Carmen Rodríguez-Cerdeira et al. MEDIATORS OF INFLAMMATION
- Whole-genome landscapes of major melanoma subtypes
- (2017) Nicholas K. Hayward et al. NATURE
- A method for normalizing pathology images to improve feature extraction for quantitative pathology
- (2016) Allison Tam et al. MEDICAL PHYSICS
- Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: A study of 522 consecutive cases
- (2011) Zhihong Chi et al. BMC CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now